• Recombinant Human EGF in 3D Glioma Spheroids

  2026-09-01

  Use recombinant human EGF as a controlled EGFR-linked perturbation in 3D glioma spheroid assays, while separating growth responses from true stemness. This practical workflow combines a streamlined 96-well tumor-spheroid method with validated reagent handling, dose design, and troubleshooting guidance.

• Fingolimod (FTY720): Assay Design for T Cells

  2026-08-31

  Fingolimod (FTY720) can serve as a mechanistic perturbation tool for separating lymphocyte availability from tumor-directed T-cell migration. This article explains how to interpret its use alongside magnetic CAR-T-mimicking platforms without confusing trafficking effects with cytotoxicity or engineering performance.

• Phosphatase Inhibitor Cocktail 3 in ER-Phagy Assays

  2026-08-30

  Phosphatase Inhibitor Cocktail 3 supports protein phosphorylation preservation in ER-phagy and infection research. This article explains how to use phosphatase control as a pre-analytical safeguard without mistaking preserved signals for proof of mechanism.

• Cyanin Chloride in a HaCaT Psoriasis Model

  2026-08-29

  A 2024 reference study examined cyanin chloride in chemical radical assays, an LPS-stimulated macrophage system, and a cytokine-induced HaCaT keratinocyte model. Its main innovation was to connect reduced inflammatory signaling, STAT3 phosphorylation, and recovery of epithelial barrier measurements, while also showing why compound identity and model boundaries matter when interpreting antioxidant findings.

• CDK7 Inhibitor Resistance and the D97N Mutation

  2026-08-29

  The reference study identifies an acquired CDK7 D97N mutation that drives resistance to non-covalent ATP-competitive CDK7 inhibitors while preserving sensitivity to covalent inhibitors. By combining resistance evolution, pharmacology, cryo-EM, and kinase ligand-affinity measurements, the work establishes a potentially general mechanism of resistance across CDK inhibitor classes.

• Concanamycin A in Cancer Biology Workflows

  2026-08-28

  Concanamycin A provides a nanomolar route to isolate V-ATPase-dependent lysosomal and trafficking biology from broader nutrient stress. This workflow-focused guide connects proton-transport inhibition with AMPK–SQSTM1/p62 signaling, apoptosis assays, invasion models, and practical formulation controls.

• Cdc42–GSK-3β/β-Catenin Signaling in Kidney Fibrosis

  2026-08-28

  The reference study identifies daphnepedunin A as a natural anti-fibrotic lead that acts directly on Cdc42 and interrupts downstream PKCζ, GSK-3β, and β-catenin signaling. Its combination of bioassay-guided discovery, thermal proteome profiling, renal fibroblast experiments, and unilateral ureteral obstruction models provides a framework for evaluating Cdc42 as a kidney fibrosis target.

• Oseltamivir acid: From Target to Translation

  2026-08-27

  Oseltamivir acid is an influenza neuraminidase inhibitor whose value depends on connecting enzyme inhibition with virion-release, resistance, and translational assay design. This article presents an evidence-layered framework for influenza antiviral research while carefully separating established antiviral findings from exploratory oncology applications.

• 1-Myristoylglycerophosphocholine in Fibrosis

  2026-08-27

  A translational perspective on how 1-myristoylglycerophosphocholine, also known as 14:0 Lyso-PC, can help researchers connect alveolar epithelial lipid remodeling with fibroblast activation, while preserving the distinction between class-level evidence and species-specific validation.

• Amyloid Beta-Peptide (1-40): Assay Workflows

  2026-08-26

  Build more reproducible Alzheimer’s disease experiments by controlling the concentration, storage history, and aggregation state of Amyloid Beta-Peptide (1-40) (human). This guide connects amyloid fibril formation studies with microglial signaling, neurotoxicity assays, and practical troubleshooting.

• Antiarrhythmic Drugs and KCa2 Channels in AF

  2026-08-26

  The reference study systematically tested established antiarrhythmic drugs against human KCa2.2 and KCa2.3 channels using automated whole-cell patch clamp. Its main finding was that dofetilide and propafenone inhibited these channels only at concentrations far above free therapeutic exposure, while Dronedarone did not emerge as a meaningful KCa2 inhibitor under the study conditions.

• Bestatin Hydrochloride: Designing Better Assays

  2026-08-25

  Bestatin hydrochloride (Ubenimex) is more than an aminopeptidase inhibitor: it is a mechanistic probe for separating peptide processing from receptor signaling. This article translates foundational neuropharmacology into better-designed angiogenesis, tumor biology, and enzyme-activity assays.

• Mestranol and Reversible Lysosomal Stress in Microglia

  2026-08-25

  A 2026 Aquatic Toxicology study identifies mestranol as an inducer of a reversible lysosomal storage–like state in zebrafish microglia. The work separates phagocytic uptake from intracellular digestion and establishes a live model for examining environmentally triggered microglial lysosomal stress.

• LNP-miR-200c Targets Dual Pathways in Pancreatic Cancer

  2026-08-24

  Yu et al. show that miR-200c suppresses pancreatic cancer through two mechanistically distinct activities: nuclear activation of PTPN6 transcription through an enhancer and post-transcriptional repression of CDH17. Encapsulation in lipid nanoparticles (LNPs) translated this mechanism into measurable antitumor activity in vivo, while also highlighting the delivery and model-validation requirements for miRNA therapeutics.

• Indazole Glucagon Receptor Antagonists: Study Insights

  2026-08-23

  The 2015 study introduced indazole-, indole-, and azaindole-based glucagon receptor antagonists derived from the MK-0893 lead series. Its combination of focused structure–activity relationship studies, scalable amide bond formation, rat pharmacokinetics, and humanized-receptor mouse models identified GRA 16d as an orally active compound for acute glucose-lowering studies.

449 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page